quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:59:28·865d
NEWSRelease
AcelRx Pharmaceuticals Inc. logo
Biomea Fusion Inc. logo
The Cigna Group logo
+17

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

ACRX· AcelRx Pharmaceuticals Inc.BMEA· Biomea Fusion Inc.CI· The Cigna GroupCRVS· Corvus Pharmaceuticals Inc.CYN· Cyngn Inc.EFTR· eFFECTOR Therapeutics Inc.
Health CareTechnologyFinance
Original source

Companies

  • ACRX
    AcelRx Pharmaceuticals Inc.
    Health Care
  • BMEA
    Biomea Fusion Inc.
    Health Care
  • CI
    The Cigna Group
    Health Care
  • CRVS
    Corvus Pharmaceuticals Inc.
    Health Care
  • CYN
    Cyngn Inc.
    Technology
  • EFTR
    eFFECTOR Therapeutics Inc.
    Health Care
  • GGE
    Green Giant Inc.
    Finance
  • HUM
    Humana Inc.
    Health Care
  • ISUN
    iSun Inc.
    Technology
  • JAN
    Janus Living Inc.
    Real Estate
  • M
    Macy's Inc
    Consumer Discretionary
  • NAAS
    NaaS Technology Inc.
    Consumer Discretionary
  • NIR
    Near Intelligence Inc.
    Technology
  • NUZE
    NuZee Inc.
    Consumer Discretionary
  • NXTP
    NextPlay Technologies Inc.
    Finance
  • ONTX
    Onconova Therapeutics Inc.
    Health Care
  • PCSA
    Processa Pharmaceuticals Inc.
    Health Care
  • PPBT
    Purple Biotech Ltd.
    Health Care
  • ROI
    RiskOn International Inc.
    Energy
  • XFOR
    X4 Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Apr 17CRVSUpdateGoldman$40.00
  • Apr 14JANUpdateScotiabank$28.00
  • Apr 14JANUpdateKeyBanc Capital Markets$28.00
  • Apr 14JANUpdateBarclays$26.00
  • Apr 14JANUpdateMorgan Stanley$28.00
  • Apr 14JANUpdateRBC Capital Mkts$27.00

Related

  • PR45m
    The Cigna Group, Leading Health Plans Advance Work to Simplify Prior Authorization
  • SEC17h
    Corvus Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update
  • PR1d
    Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
  • SEC1d
    SEC Form 6-K filed by Purple Biotech Ltd.
  • PR1d
    Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform
  • PR1d
    The Cigna Group Declares Quarterly Dividend
  • SEC2d
    SEC Form SCHEDULE 13G filed by Cyngn Inc.
  • INSIDER2d
    SEC Form 3 filed by new insider Field Robert Stuart
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022